Observational analysis shows significant volume reduction in 45 patients with benign thyroid nodules after percutaneous ablation, highlighting its safety compared to surgery.
Key Points
Percutaneous radiofrequency ablation significantly reduced thyroid nodule volume by 79.66% at one year follow-up.
Among the 45 patients treated, 79.66% reported symptom relief following the procedure.
This single-center experience involved patients categorized under TIRADS 1 or 2 and BETHESDA II scoring.
Findings suggest that percutaneous ablation could serve as a preferred alternative to surgical intervention for benign thyroid nodules.